Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome

Thrombosis and Haemostasis

Volumn 94, Issue 1, 2005, Pages 82-87

  Kolev, Krasimir ^a   Léránt, István ^a   Skopál, Judit ^a   Kelemen, Anna ^a   Nagy, Zoltán ^a   Machovich, Raymund ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antiphospholipid syndrome; Antithrombin; Hirudin; Protein C; Thrombin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HIRUDIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; LEVOTHYROXINE; PERINDOPRIL; THROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CASE REPORT; FEMALE; HEMIPARESIS; HOSPITAL ADMISSION; HUMAN; INHIBITION KINETICS; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; SPONTANEOUS ABORTION; THROMBOSIS; WESTERN BLOTTING;

ADULT; ANTIGENS; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOTTING, WESTERN; FACTOR XIII; FEMALE; FIBRINOGEN; HIRUDINS; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTEIN C; THROMBIN; TIME FACTORS;

EID: 22144464114     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-11-0766     Document Type: Article

References (18)

1. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-53.
2. Roubey RAS. Immunology of the antiphospholipid syndrome: antibodies, antigens and autoimmune response. Thromb Haemost 1999; 82: 656-61.
3. Lieby P, Soley A, Levallois H et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals extreme antibody heterogeneity. Blood 2001; 97: 3820-8.
4. Hwang KK, Grossman JM, Visvanathan S et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol 2001; 167: 7192-8.
5. Yang CD, Hwang KK, Yan W et al. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol. 2004; 172: 5765-73.
6. Kolev K, Gombás J, Váradi B et al. Immunoglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin. Thromb Haemost 2002; 87: 502-8.
7. Cugno M, Dominguez M, Cabibbe M et al. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome. Brit J Haematol 2000; 108: 871-5.
8. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
9. Olson ST, Björk I, Shore JD. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Meth Enzymol 1993; 222: 525-59.
10. Esmon NL, DeBault LE, Esmon CT. Proteolytic formation and properties of γ-carboxyglutamic acid-domainless protein C. J Biol Chem 1983; 258: 5548-53.
11. Lundblad RL, Kingdon HS, Mann KG. Thrombin. Meth Enzymol 1976; 45: 156-76.
12. Váradi B, Kolev K, Tenekedjiev K et al. Phospholipid-barrier to fibrinolysis: role for the anionic polar head charge and the gel-phase crystalline structure. J Biol Chem 2004; 279: 39863-71.
13. Doyle MF, Mann KG. Multiple active forms of thrombin. J Biol Chem 1990; 265: 10693-701.
14. Gan ZR, Li Y, Chen Z et al. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem 1994; 269: 1301-5.
15. Rydel TJ, Ravichandran KG, Tulinsky A et al. The structure of recombinant hirudin and human α-thrombin. Science 1990; 249: 277-80.
16. Musci G, Berliner LJ, Esmon CT. Evidence for multiple conformational changes in the active center of thrombin induced by complex formation with thrombomodulin: an analysis employing nitroxide spin-labels. Biochemistry 1988; 27: 769-73.
17. Philipou H, Rance J, Myles T et al. Roles for low specificity and cofactor interactions sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate. J Biol Chem 2003; 278: 32020-6.
18. Hwang KK, Yang CD, Yan WH et al. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arth Rheum/AR C Res 2003; 48: 1622-30.